Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

Go back to Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 7c

May 11, 2022 7:10 AM EDT

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

... More